Cryptococcus neoformans variety gattii

Medical Mycology

Volumn 39, Issue 2, 2001, Pages 155-168

  Sorrell, T C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Biology; Cryptococcus neoformans var. gattii; Epidemiology; Taxonomy

Indexed keywords

ANTIFUNGAL AGENT; LACCASE; LYSOPHOSPHOLIPASE; POLYSACCHARIDE;

AUSTRALIA; BIOCHEMISTRY; BIOLOGY; BRAIN INFECTION; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; ENVIRONMENTAL EXPOSURE; ENZYME RELEASE; EUCALYPTUS; HOST; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INHALATION; LIFE CYCLE; LUNG MYCOSIS; MATING TYPE; MORBIDITY; NONHUMAN; PATHOGENESIS; POPULATION RISK; REPRODUCTION; REVIEW; RISK FACTOR; SEROTYPE; TAXONOMY; TREE; VIRULENCE; WOOD; YEAST;

CRYPTOCOCCUS NEOFORMANS; EUCALYPTUS;

EID: 0035039544     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.39.2.155.168     Document Type: Review

References (155)

1. Kwon-Chung KJ, Bennett JE, Rhodes JC. Taxonomic studies on Filobasidiella species and their anamorphs. Antonie van Leeuwenhoek 1982; 48: 25-38.
2. Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. grubii: Separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol 1999; 37: 838-840.
3. Boekhout T, Theelan B, Diaz M, et al. Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology 2001; 147: 891-907.
4. Kwon-Chung KJ. A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes. Mycologia 1976; 68: 942-946.
5. Vanbreuseghem R, Takashio M. An atypical strain of Cryptococcus neoformans (San Felice) Vuillemin 1894. Part II. Cryptococcus neoformans var gattii var. nov. Ann Soc Belg Med Trop 1970; 50: 695-702.
6. Gatti F, Eeckels R. An atypical strain of Cryptococcus neoformans (Sanfelice) Vuillemin. Part 1. Description of the disease and of the strain. Ann Soc Belg Med Trop 1970; 50: 689-694.
7. Kwon-Chung KJ. A new genus, Filobasidiella, the perfect state of Cryptococcus neoformans. Mycologia 1975; 67: 1197-1200.
8. Kwon-Chung KJ. Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans. Mycologia 1976; 68: 821-833.
9. Aulakh HS, Straus SE, Kwon-Chung KJ. Genetic relatedeness of Filobasidiella neoformans (Cryptococcus neoformans) and Filobasidiella badllispora (Cryptococcus bacillispoms) as determined by DNA base composition and sequence homology studies. Int J Syst Bacterial 1981; 31: 97-103.
10. Kwon-Chung KJ, Bennett JE. Cryptococcosis. In: Kwon-Chung KJ, Bennett JE, eds. Medical Mycology. Philadelphia: Lea & Febiger, 1992: 397-445.
11. Swann E, Taylor JW. Phylogenetic diversity of yeast-producing basidiomycetes. Mycol Res 1995; 99: 205-210.
12. Swann E, Taylor JW. Toward a phylogenetic systematics of the Basidiomycota: integrating yeasts and filamentous basidiomycetes using 18S rRNA gene sequences. Stud Mycol 1995; 38: 147-162.
13. Swann E, Taylor JW. Phylogenetic perspectives on basidiomycete systematics: evidence from the 18S rRNA gene. Can J Bot 1995; 73 (Suppl. 1): S862-S868.
14. Fell JW, Boekhout T, Fonseca A, Scorzetti G, Statzell-Tallman A. Biodiversity and systematics of basidiomycetous yeasts as determined by large-subunit rDNA D1/D2 domain sequence analysis. Int J Syst Evol Microbiol 2000; 50: 1351-1371.
15. McLaughlin E, Frieders M, Lu H. A microscopist's view of heterobasidiomycete phylogeny. Stud Mycol 1995; 38: 91-110.
16. Kwon-Chung KJ, Chang YC. Gene arrangement and sequence of the 5S rRNA in Filobasidieüa neoformans (Cryptococcus neoformans) as a phylogenetic indicator. Int J Syst Bacterial 1994; 44: 209-213.
17. Kwon-Chung KJ. Filobasidiella Kwon-Chung. In: Kurtzman CD, Fell JW, eds. The Yeasts, a Taxonomic Study, 4th edn. Amsterdam: Eisevier, 1998: 656-662.
18. Xu J, Vilgalys R, Mitchell TG. Multiple gene geneologies reveal recent dispersion and hybridization in the human pathogenic fungus Cryptococcus neoformans. Mol Ecol 2000; 9: 1471-1481.
19. Kurtzman CP. Nuclear DNA hybridization: Quantitation of close genetic relationships. In: Kurtzman CP, Fell JW, eds. The Yeasts, a Taxonomic Study, 4th edn. Amsterdam: Elsevier, 1998: 63-68.
20. Boekhout T, Van Belkum A, Leenders AP, et al. Molecular typing of Cryptococcus neoformans: taxonomic and epidemiological aspects. Int J Syst Bacteriol 1997; 47: 432-442.
21. Wickes BL, Moore TDE, Kwon-Chung KJ. Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans. Microbiology 1994; 140: 543-550.
22. Ruma P, Chen SCA, Sorrell TC, Brownlee AG. Characterization of Cryptococcus neoformans by random DNA amplification. Lett App Microbiol 1996; 23: 312-316.
23. Sorrell TC, Chen SCA, Ruma P, et al. Concordance of clinical and environmental isolates of Cryptococcus neoformans var gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting. J Clin Microbiol 1996; 34: 1253-1260.
24. Meyer W, Mitchell TG, Freedman EZ, Vilgalys R. Hybridization probes for conventional DNA fingerprinting used as single primers in the polymerase chain reaction to distinguish strains of Cryptococcus neoformans. J Clin Microbiol 1993; 31:2274-2280.
25. Meyer W, Mitchell TG. Polymerase chain reaction fingerprinting in fungi using single primers specific to minisatellites and simple repetitive DNA sequences: strain variation in Cryptococcus neoformans. Electrophoresis 1995; 16: 1468-1656.
26. Varma A, Kwon-Chung KJ. Restriction fragment polymorphism in mitochondrial DNA of Cryptococcus neoformans. J Gen Microbiol 1989; 135: 3353-3362.
27. Varma A, Swinne D, Staib F, Bennett JE, Kwon-Chung KJ. Diversity of DNA fingerprints in Cryptococcus neoformans. J Clin Microbiol 1995; 33: 1807-1814.
28. Soil DR. The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev 2000; 13: 332-370.
29. Hillis DM, Moritz C, Mable BK (eds). Molecular Systematics, 2nd edn. Sunderland, MA: Sinauer, 1998.
30. Fan M, Currie BP, Gutell RR, Ragan MA, Casadevall A. The 16S, 5.8S and 23S-like rRNAs of the two varieties Cryptococcus neoformans: sequence, secondary structure, phylogenetic analysis and restriction fragment polymorphisms. / Med Vet Mycol 1994; 32: 163-180.
31. Gueho E, Improvisi L, Christen R, de Hoog GS. Phylogenetic relationships of Cryptococcus neoformans and some related basidiomycetous yeasts determined from partial large subunit rRNA sequences. Antonie van Leeuwenhoek 1993; 63: 175-189.
32. Nakamura Y, Kano R, Watanabe S, Hasegawa A. Molecular analysis of CAP59 gene sequences from five serotypes of Cryptococcus neoformans. J Clin Microbiol 2000; 38: 992-995.
33. Imai T, Watanabe K, Tamura M, et al. Geographic grouping of Cryptococcus neoformans var. gattii by random amplified polymorphic DNA fingerprint patterns and ITS sequence divergence. Clin Lab 2000; 46: 345-354.
34. Brandt ME. Bragg SL, Pinner RW. Multilocus enzyme typing of Cryptococcus neoformans. J Clin Microbiol 1993; 31: 2819-2823.
35. Brandt ME, Hutwagner LC, Kuykendall RJ. Pinner RW and the Cryptococcal Disease Active Surveillance Group. Comparison of multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for molecular subtyping of Cryptococcus neoformans. J Clin Microbiol 1995; 33: 1890-1895.
36. Bertout S, Renaud F, Swinne D, Mallie M, Bastide JM. Genetic multilocus studies of different strains of Cryptococcus neoformans: taxonomy and genetic structure. / Clin Microbiol 1999: 37: 715-720.
37. Kwon-Chung KJ, Polacheck I, Bennett JE. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotype A and D) and Cryptococcus neoformans var. gattii (serotype B and C). J Clin Microbiol 1982: 15: 535-537.
38. Min KH, Kwon-Chung KJ. Biochemical bases for the distinction of the two C. neoformans varieties with CGB medium. Zentralbl Bakteriol Microbiol Hyg 1986: 261: 471-476.
39. Ikeda R, Jacobson ES. Heterogeneity of phenol oxidases in Cryptococcus neoformans. Infect Immun 1992; 60: 3552-3555.
40. Safrin RE. Lancaster LA, Davis CE, Braude AI. Differentiation of Cryptococcus neoformans serotypes by isoenzymes electrophoresis. Am J Clin Path 1986; 86: 204-208.
41. Hamilton AJ, Holdom MD. Biochemical comparison of the Cu,Zn Superoxide dismutases of Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. gattii. Infect Immun 1997; 65: 488-494.
42. Kwon-Chung KJ. Sorrell TC, Dromer F, Fung E. Levitz SM. Cryptococcosis: clinical and biological aspects. Med My col 2001: 38 (Suppl. 1): 205-213.
43. Himmelreich U, Bourne RP, Somorjai RL, Mountford CE. Sorrell TC. Identification and classification of pathogenic microorganisms based on 1H MR spectroscopy of cell suspensions. MAGMA 2000; 11 (Suppl. 1): 199.
44. Ikeda R. Shinoda T, Fukazawa Y, Kaufman L. Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. / Clin Microbiol 1982; 16:22-29.
45. Eckert FT, Kozel TR. Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide. Infect Immun 1987; 55: 1895-1899.
46. Cherniak R, Sundstrom JB. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun 1994; 62: 1507-1515.
47. Belay T. Cherniak R. Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay. Infect Immun 1995: 63: 1810-1819.
48. 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin Diagn Lab Immunol 1998: 5: 146-159.
49. Hamilton AJ, Bartholomew MA, Figuero JI, Fenelon LE. Hay RJ. Murine monoclonal antibodies recognizing a noncapsular antigen that distinguishes between Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. gattii. Trans R Soc Med Hyg 1991: 86: 123-127.
50. Hamilton AJ, Figueroa JI, Jeavons L, Seaton RA. Recognition of cytoplasmic yeast antigens of Cryptococcus neoformans var. gattii by immune human sera. FEMS Immunol Med Microbiol 1997; 17: 111-119.
51. Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol 1990; 28: 1642-1644.
52. Pfeiffer TJ, Ellis DH. Environmental isolation of Cryptococcus neoformans var. gattii from Eucalyptus tereticornis. J Med Vet My col 1992; 30: 407-408.
53. Zacharin RF. Emigrant Eucalypts: Gum Trees as Exotics. Melbourne: Melbourne University Press. 1978.
54. Chippendale GM. Flora of Australia. Bureau of Flora and Fauna. Canberra: Australian Government Publishing Service. 1998: 19.
55. Laurenson IF, Lalloo DG. Naraqi S, et al. Cryptococcus neoformans in Papua New Guinea: a common pathogen but an elusive source. J Med Vet My col 1997; 35: 437-440.
56. Laurenson I. Naraqi S, Howcroft N, Burrows I, Saulei S. Cryptococcal meningitis in Papua New Guinea: ecology and the role of eucalypts. Med J Aust 1993; 158: 213.
57. Ellis D. Pfeiffer T. Ruma P. Brownlee A. Chen S. Sorrell T. Distribution and frequency of C. neoformans var. gattii among the species of Eucalyptus. In: Program and Abstracts 3rd International Conference on Cryptococcus and Cryptococcosis, Paris. France: Sept 22-26, 1996. Paris: Institut Pasteur, 1996: Abstract 11.5.
58. Pfeiffer TJ, Ellis DH. Additional eucalypt hosts for Cryptococcus neoformans var. gattii. In: Abstracts of the 13th Congress of the International Society for Human and Animal Mycology (ISHAM). Parma. Italy: Jun 8-13. 1997. Parma: University of Parma. 1997: Abstract Pill.
59. Ellis D. Pfeiffer T. Cryptococcosis and the ecology of Cryptococcus neoformans. Jpn J Med Mycol 1994;. 35: 111-122.
60. Chakrabarti A, Jatana M, Kumar P. Chatha L. Kaushal A, Padhye AA. Isolation of Cryptococcus neoformans var. gattii from Eucalyptus camaldulensis in India. J Clin Microbiol 1997: 35:3340-3342.
61. Montagna MT, Viviani MA. Pulito A, et al. Cryptococcus neoformans var. gattii in Italy. Environmental investigation related to an autochtonous clinical case in Apulia. / Mycol Med 1997; 7: 93-96.
62. Montenegro H. Paula CR. Environmental isolation of Cryptococcus neoformans var. gattii and Cryptococcus neoformans var. neoformans in the city of Sao Paulo. Brazil. Med Mycol 38: 385-390.
63. Swinne D, Taelman H, Batungwanayo J. Bigirankana A, Bogaerts J. Ecology of Cryptococcus neoformans in central Africa. Med Trop 1994; 54: 53-55.
64. Gezuele E, Calegari L. Sanabria D. Davel G. Civila E. Isolation of Cryptococcus neoformans var. gattii from nest of the wasp. Polybia occidentalis. Rev Iberoam Micol 1993: 10: 5-6.
65. Lazera MS. Wanke B, Nishikawa MM. Isolation of both varieties of Cryptococcus neoformans from saprophytic sources in the city of Rio de Janeiro. Brazil. J Med Vet Mvcol 1993; 31: 449-454.
66. Lazera MS. Salmito Cavalcanti MA. Londero AT. Trilles L. Nishikawa MM. Wanke B. Possible primary ecological niche of Cryptococcus neoformans. Med Mycol 2000: 38: 379-383.
67. Fortes ST, Lazera M, Macedo RL, et al. Cryptococcus neoformans var. gattii in Brazilian tropical rain forest. In Programme and Abstracts of the 4th International Conference on Cryptococcus and Cryptococcosis, London, UK, September 12-16, 1999. London: The Royal Society, 1999: Abstract PC 28.
68. Callejas A, Ordonez N, Rodriguez MC, Castoneda E. First isolation of Cryptococcus neoformans var. gattii serotype C from the environment in Colombia. Med Mycol 1998; 36: 341-344.
69. Castaneda E, Ordonez N, Callejas A, Rodriquez MC, Castaneda A, Huerfano S. In search of the habitat of Cryptococcus neoformans var. gattii in Colombia. In; Program and Abstracts of the 4th International Conference on Cryptococcus and Cryptococcosis, London, UK, September 12-16, 1999. London: The Royal Society, 1999: Abstract 136.
70. Ellis DH, Pfeiffer TJ. Ecology, life cycle, and infectious propagule of Cryptococcus neoformans. Lancet 1990; 336: 923-925.
71. Wang P, Perfect JR, Heitman J. The G-protein βsubunit GPB1 is required for mating and haploid fruiting in Cryptococcus neoformans. Mol Cell Biol 2000; 20: 352-362.
72. Wickes BL, Mayorga ME, Edman U, Edman JC. Dimorphism and haploid fruiting in Cryptococcus neoformans: Association with the a-mating type. Proc Natl Acad Sei 1996; 93: 7327-7331.
73. Ellis D, Pfeiffer T. The ecology of Cryptococcus neoformans. Eur J Epidmiol 1992; 8: 321-325.
74. Taylor JW, Geiser DM, Burt A, Koufopanou V. The evolutionary biology and population genetics underlying fungal strain typing. Clin Microbiol Rev 1999; 12: 126-146.
75. Halliday CL, Bui T, Krockenberger M, Malik R, Ellis DH, Carter DA. Presence of a and a mating types in environmental and clinical collections of Cryptococcus neoformans var. gattii strains from Australia. J Clin Microbiol 1999; 37: 2920-2926.
76. Halliday CK. A molecular study of mating type and recombination in Cryptococcus neoformans var. gattii. PhD thesis, University of Sydney, 2001.
77. Madrenys N, De Vroey C, Raes-Wuytack C, Torres-Rodrigues JM. Identification of the perfect state of Cryptococcus neoformans from 195 clinical isolates including 84 from AIDS patients. Mycopathologia 1993; 123: 65-68.
78. Kwon-Chung KJ, Edman JC, Wickes BL. Genetic association of mating types and virulence in Cryptococcus neoformans. Infect Immun 1992; 60: 602-605.
79. Kwon-Chung KJ and Bennett JE. Distribution of a and a mating types of Cryptococcus neoformans among natural and clinical isolates. Am J Epidem 1978; 108: 337-340.
80. Franzot SP, Hamdan JS, Currie BP, Casadevall A. Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure. J Clin Microbiol 1997; 35: 2243-2251.
81. Lengeler KB, Wang P, Cox GM, Perfect JR, Heitman J. Identification of the MATa mating-type locus of Cryptococcus neoformans reveals a serotype A MATa strain thought to have been extinct. Proc Natl Acad Sei USA 2000; 19: 14455-14460.
82. Boekhout T, Theelan B, Abeln E, Diaz M, Fell JW. Population genetics based epidemiology of Cryptococcus neoformans. In: Programme and Abstracts of the 4th International Conference of Cryptococcus and Cryptococcosis, London, UK, September 12-16, 1999. London: The Royal Society, 1999: Abstract 134.
83. Kwon-Chung KJ, Bennett JE. Epidemiologie differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984; 120: 123-130.
84. Nishikawa MM, Leite P, Cavalcante M do A, et al. Serotyping of Cryptococcus neoformans isolates of clinical and environmental sources from Brazil. In: Program and Abstracts of the 4th International Conference on Cryptococcus and Cryptococcosis, London, UK, September 12-16, 1999. London: The Royal Society, 1999: Abstract PC 21.
85. Sukroongreung S, Nilakul C, Ruangsomboon O, Chuakul W, Eampokalap B. Serotypes of Cryptococcus neoformans isolated from patients prior to and during the AIDS era in Thailand. Mycopathologia 1996; 135: 75-78.
86. Poonwan N, Mikami Y, Poosuwan S, et al. Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents. Eur J Epidem 1997; 13: 335-340.
87. Keah KC, Parameswari S, Cheong YM. Serotypes of clinical isolates of Cryptococcus neoformans in Malaysia. Trop Biomed 1994; 11: 205-207.
88. Currie BJ, Vigust T, Leach G, Dwyer B. Cryptococcus neoformans var. gattii. Lancet 1990; 336: 1442.
89. Seaton RA, Naraqi S, Wembri JP, Warrell DA. Predictors of outcome in Cryptococcus neoformans var. gattii meningitis. Q J Med 1996; 89: 423-428.
90. Seaton RA, Hamilton AJ, Hay RJ, Warrell DA. Exposure to Cryptococcus neoformans var gattii - a seroepidemiological study. Trans Roy Soc Trop Med Hyg 1996; 90: 508-512.
91. Castanon-Olivares LR, Arreguin-Espinosa R, Ruiz-Palacios y Santos G, Lopez-Martinez R. Frequency of Cryptococcus species and varieties in Mexico and their comparison with some Latin American countries. Rev Latinoam Microbiol 2000; 42: 35-0.
92. Crewe-Brown H, Karstaedt A, Khoosal M, Bhagoobhai L, Dromer F, Ronin O. A 10 year study of cryptococcal meningitis. In: Program and Abstracts of the 4th International Conference on Cryptococcus and Cryptococcosis. London, UK, September 12-16, 1999. London: The Royal Society, 1999: Abstract F6.
93. Lopez-Martinez R, Soto-Hernandez JL, Ostrosky-Zeichner L, Castanon-Olivares LR, Angeles-Morales V, Sotelo J. Cryptococcus neoformans var. gattii among patients with cryptococcal meningitis in Mexico. First observations. Mycopathologia 1996; 134: 61-64.
94. Padhye AA, Chakrabarti A, Chander J, Kaufman L. Cryptococcus neoformans var. gattii in India. J Med Vet My col 1993; 31: 165-168.
95. Chander J, Sapra RK, Talwar P. Incidence of cryptococcosis in and around Chandigarh, India, during the period 1982-1991. Mycoses 1994; 37: 23-26.
96. Abraham M, Mathews V, Ganesh A, John TJ, Mathews MS. Infection caused by Cryptococcus neoformans var. gattii serotype B in an AIDS patient in India. J Med Vet Mycol 1997; 35: 283-284.
97. Li A, Nishimura K, Taguchi H, Tanaka R, Wu S, Miyaji M. The isolation of Cryptococcus neoformans from pigeon droppings and serotyping of naturally and clinically sourced isolates in China. Mycopathologia 1993; 124: 1-5.
98. Hsu MM, Chang JC, Yokoyama K, Nishimura K, Miyaji M. Serotypes and mating types of clinical strains of Cryptococcus neoformans isolated in Taiwan. Mycopathologia 1994; 125: 77-81.
99. Chen YC, Chang SC, Shih CC, et al. Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan. Diagn Microbiol Infect Dis 2000; 36: 175-183.
100. Bustamante Rufino B, Swinne D. Cryptococciis neoformans var. gattii isolates from two Peruvian patients. Rev Iberoam Micol 1998; 15: 22-24.
101. Bava AJ, Negroni R. The epidemiological characteristics of 105 cases of cryptococcosis diagnosed in the Republic of Argentina between 1981-1990. Rev Inst Med Trop de Sao Paulo. 1992; 34: 335-340.
102. Bogaerts J, Rouvroy D, Taelman H, et al. AIDS associated cryptococcal meningitis in Rwanda (1983-1992): epidemiologic and diagnostic features. J Infect 1999; 39: 32-37.
103. Montagna MT, Tortorano AM, Fiore L. Ingletti AM. Barbuti S. Cryptococcits neoformans var. gattii en Italie. Note I. Premier cas autochtone de méningite àsérotype B chez un sujet VIH positif. J Mycol Med 1997; 7: 90-92.
104. Viviani MA. Swinne D. Kouzmanov A, et al. Survey of cryptococcosis in Europe. The European Confederation of Medical Mycology Working Group Report. Iberoam Micol 2000; 17: S144-145.
105. Veleqraki A, Kiossis VG, Pitsouni H. Toukas D. Dauiilidis VD, Legakis NJ. First report of Cryptococciis neoformans var. gattii serotype B in Greece. Med Mycol 2001; 39: In press.
106. Chen SCA, Sorrell TC. Nimmo G, et al. Epidemiology and host and variety-dependent characteristics of infection due to Cryptococciis neoformans in Australia and New Zealand. Clin Infect Dis 2000; 31: 499-508.
107. Connolly JH, Krockenberger MB, Malik R. Canfield PJ, Wigney DI. Muir DB. Asymptomatic carriage of Cryptococciis neoformans in the nasal cavity of the koala (Phascolarctos cinereus). Med Mycol 1999; 37: 331-338.
108. Hindell MA , Lee AK. Tree preferences of the Koala. In: Lee AK. Handasyde KA. Sanson GD, eds. Biology of the Koala. Sydney: Surrey Beatty and Sons, 1990: 117-121.
109. Sorrell TC, Brownlee AG, Ruma P. Malik R, Pfeiffer TJ, Ellis DH. Natural environmental sources of Cryptococciis neoformans var. gattii. .1 Clin Microbiol 1996; 34: 1261-1263.
110. Chen SC, Currie BJ, Campbell HM, et al. Cryptococciis neoformans var. gattii infection in northern Australia: existence of an environmental source other than known host eucalypts. Trans R Soc Trop Med Hyg 1997; 91: 547-550.
111. Hamann ID, Gillespie RJ, Ferguson JK. Primary cryptococcal cellulitis caused by Cryptococciis neoformans var. gattii in an immunocompetent host. Aust J Dermatol 1997; 38: 29-32.
112. Casadevall A, Perfect JR (eds). Animal models and veterinary aspects of cryptococcosis. In: Cryptococcosis. Washington: ASM Press, 1998: 325-350.
113. Irokanulo EAO, Akueshi CO. Virulence of Cryptococcits neoformans serotypes A, B, C and D for four mouse strains. J Med Microbiol 1995; 43: 289-293.
114. Chen SCA, Muller M, Zhou JZ, Wright LC, Sorrell TC. Phospholipase activity in Cryptococciis neoformans: a new virulence factor? J Inf Dis 1997; 175: 414-420.
115. Kwon-Chung KJ, Wickes BL, Stockman L, Roberts GD. Ellis D, Howard DH. Virulence, serotype and molecular characteristics of environmental strains of Cryptococciis neoformans var. gattii. Infect Immun 1992; 60: 1869-1874.
116. Allen C. Distinguishing tumours from fungal lesions using proton magnetic resonance spectroscopy. Honours thesis. Department of Medicine, University of Sydney, 1996.
117. Alspaugh JA, Perfect JR, Heitman J. Signal transduction pathways regulating differentiation and pathogenicity of Cryptococciis neoformans. Fungal Genet Bio/ 1998; 25: 1-14.
118. Wickes BL, Edman U, Edman JC. The Cryptococciis neoformans STE12a gene: a putative Saccharomvces cerevisiae STE12 homologue that is mating type specific. Mol Microbiol 1997; 26: 951-960.
119. Williamson PR. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: Identification as a laccase. / Bacterial 1994; 176: 656-664.
120. Yue C. Cavallo LM. Alspaugh JA. et al. The STE12a homologue is required for haploid filamentation but is largely dispensible for mating and virulence in Cryptococcus neoformans. Genetics 1999: 153: 1601-1615.
121. Chang YC, Wickes BL, Miller GF. Penoyer LA. Kwon-Chung KJ. Cryptococcus neoformans STE12a regulates virulence but is not essential for mating. J Exp Med 2000; 191: 871-881.
122. Chen L-C. Blank E. Casadevall A. Extracellular proteinase activity of Cryptococcus neoformans. Clin Diagn Lab fmmiinol 1996; 3: 570-574.
123. Ruma-Haynes P. Brownlee AG, Sorrell TC. A rapid method for detecting extracellular proteinase activity in Cryptococcus neoformans and a survey of 63 isolates. J Med Microbiol 2000: 49: 733-737.
124. Himmelreich U. Dzendrowskyj TE, Allen C. et al. Cryptococcomas distinguished from gliomas by magnetic resonance spectroscopy - an experimental rat and cell culture study. Radiology 2001: in press.
125. Santangelo RT. Nouri-Sorkhabi MH. Sorrell TC, et al. Biochemical and functional characterisation of secreted phospholipase activities from Cryptococcus neoformans in their naturally occurring state. J Med Microbiol 1999; 48: 1-10.
126. Chen SCA, Wright LC. Golding JC. Sorrell TC. Purification and characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus, Cryptococcus neoformans. Biochem J 2000: 347: 431-439.
127. Cox GM. McDade HC. Chen SC. et al. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 2001; 39: 166-175.
128. Rozenbaum R, Goncalves AR. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 1994: 18: 369-380.
129. Speed B. Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995; 21: 28-34.
130. Speed BR. Strawbridge L. Ellis DH. Cryptococcus neoformans var. gattii meningitis in an Australian patient with AIDS. J Med Vet My col 1993: 31: 395-399.
131. Marriott DJR. Speed BR. Spelman D. Shaw D. French M. Harkness JL. Cryptococcus neoformans var. gattii infection in Australian HIV-infected patients: a review of 7 cases. In: Program and Abstracts of the Third International Conference on Cryptococcus and Cryptococcosis, Paris, France. September 22-26. 1996. London: The Royal Society. 1996: Abstract PO 3.10.
132. Seaton RA. Wembri JP. Armstrong P. Ombiga J. Naraqi S. Kevau I. Symptomatic human immunodeficiency virus (HIV) infection in Papua New Guinea. Aitst N Z J Med 1996: 26: 783-788.
133. Castanon-Olivares LR. Lopez-Martinez R, Barriga-Angulo G. Rios-Rosas C. Cryptococcus neoformans var. gattii in an AIDS patient: first observation in Mexico. J Med Vet My col 1997; 35: 57-59.
134. Clancy MN. Fleischmann J. Howard DH, Kwon-Chung KJ, Shimizo RY. Isolation of Cryptococcus neoformans gattii from a patient with AIDS in Southern California. J Infect Dis 1990; 161: 809.
135. Kapend'a K, Komichelo K, Swinne D, Vandepitte J. Meningitis due to Cryptococcus neoformans biovar gattii in a Zairean AIDS patient. Eur J Clin Microbiol 1987; 6: 320-321.
136. St-Germain G, Noël G, Kwon-Chung KJ. Disseminated cryptococcosis due to Cryptococcus neoformans variety gattii in a Canadian patient with AIDS. Eur J Clin Microbiol Infect Dis 1988; 7: 587-588.
137. Dromer F, Ronin O, Dupont B. Isolation of Cryptococcus neoformans var. gattii from an Asian patient in France: evidence for dormant infection in healthy subjects. J Med Vet Mycol 1992; 30: 395-397.
138. Ellis DH. Cryptococcus neoformans var. gattii in Australia. J Clin Microbiol 1987; 25: 430-431.
139. De Whytt CN, Dickson PL, Holt GW. Cryptococcal meningitis. A review of 32 years experience. J Neurol Sei 1982; 53:283-292.
140. Fisher D, Lo D, Burrow J, Currie B. Cryptococcus neoformans in tropical northern Australia: predominantly variant gattii with good outcomes. Aust NZ Med 1993; 23: 678-682.
141. Van Dam MG, Seaton RA, Hamilton AJ. Analysis of HLA association in susceptibility to infection with Cryptococcus neoformans var. gattii in a Papua New Guinean population. Med Mycol 1998; 36: 185-188.
142. Malik R, Wigney DI, Muir DB, Gregory DJ, Love DN. Cryptococcosis in cats: clinical and mycological assessment of 29 cases and evaluation of treatment using orally administered fluconazole. / Med Vet Mycol 1992; 30: 133-144.
143. Malik R, Dill-Macky E, Martin P, et al. Cryptococcosis in dogs: a retrospective study of 20 consecutive cases. J Med Vet Mycol 1995; 33: 291-297.
144. Riley CB, Bolton JR, Mills JN, Thomas JB. Cryptococcosis in seven horses. Aust Vet J 1992; 69: 135-139.
145. Spencer A, Ley C, Canfield P, Martin P, Perry R. Meningoencephalitis in a koala (Phascolarctos cinereus) due to Cryptococcus neoformans var. gattii infection. J Zoo Wildlife Med 1993; 24: 519-522.
146. Malik R, Martin P, McGill J, Martin A, Love DN. Successful treatment of invasive nasal cryptococcosis in a ferret. Aus Vet J 2000; 78: 158-159.
147. Hill FI, Woodgyer AJ, Lintott MA. Cryptococcosis in a North Island brown kiwi (Aptéryx australis mantelli) in New Zealand. J Med Vet My col 1995; 33: 305-309.
148. Bolton LA, Lobetti RG, Evezard DN, et al. Cryptococcosis in captive cheetah (Acinonyx jubatus): two cases. J S Afr Vet Assoc 1999; 70: 35-39.
149. Baro T, Torres-Rodriguez JM, De Mendoza MH, Morera Y, Alia C. First identification of autochthonous Cryptococcus neoformans var. gattii isolated from goats with predominantly severe pulmonary disease in Spain. J Clin Microbiol 1998; 36: 458-461.
150. Mitchell DH, Sorrell TC, Allworth AM, et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995; 20: 611-616.
151. Mitchell DH, Sorrell TC. Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii. Clin Infect Dis 1992; 14: 1142-1144.
152. Lalloo D, Fisher D, Naraqi S, et al. Cryptococcal meningitis (C. neoformans var. gattii) leading to blindness in previously healthy melanesian adults in Papua New Guinea. Q J Med 1994; 87: 343-349.
153. Seaton RA, Verma N, Naraqi S, Wembri JP, Warrell DA. Visual loss in immunocompetent patients with Cryptococcus neoformans var. gattii meningitis. Trans R Soc Med Hyg 1997; 91: 44-49.
154. Moosa MYS, Coovadia YM. Cryptococcal meningitis in Durban, South Africa: A comparison of clinical features, laboratory findings and outcome for human immunodeficiency virus (HlV)-positive and HIV-negative patients. Clin Infect Dis 1997; 24: 131-134
155. Andrews A, Pfeiffer T, Bell J, Ellis D. In vitro activity of terbinafine and fluconazole against 205 clinical and environmental isolates of Cryptococcus neoformans. In: Programme and Abstracts of 4th International Conference of Cryptococcus and Cryptococcosis, London, UK, September 12-16, 1999. London: The Royal Society, 1999: Abstract PC 30.